You are here

  • Home
  • Archive
  • Volume 88, Issue 3
  • Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

Article metrics

Article menu

Download PDFPDF

Multiple sclerosis
Research paper
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis
Free

 

Online download statistics by month:

Online download statistics by month: September 2016 to July 2022

AbstractFullPdf
Sep 2016121714
Oct 201673691181
Nov 20164052832
Dec 20163931026
Jan 20173581630
Feb 201728327138
Mar 201728156151
Apr 201727183100
May 201724140104
Jun 2017527549
Jul 2017967322
Aug 20171086928
Sep 20171066037
Oct 20171067137
Nov 20171118343
Dec 2017795127
Jan 2018946332
Feb 2018935621
Mar 2018896130
Apr 20181319528
May 20181149125
Jun 20181028024
Jul 2018743512
Aug 2018795817
Sep 2018623210
Oct 20181045525
Nov 2018705529
Dec 2018483416
Jan 2019393213
Feb 2019463210
Mar 2019847021
Apr 2019603812
May 2019644128
Jun 2019493218
Jul 2019574519
Aug 2019342717
Sep 2019494223
Oct 2019372616
Nov 2019292715
Dec 20192473410
Jan 2020312812
Feb 2020453620
Mar 2020504122
Apr 202020169
May 2020453717
Jun 2020928516
Jul 2020433320
Aug 2020292313
Sep 2020564716
Oct 2020484719
Nov 202028287
Dec 202018146
Jan 202129206
Feb 2021262215
Mar 2021222010
Apr 2021302010
May 202120175
Jun 2021282726
Jul 2021393715
Aug 2021211910
Sep 2021362813
Oct 2021383533
Nov 2021221718
Dec 2021363010
Jan 2022352910
Feb 202246407
Mar 2022422810
Apr 2022103206
May 2022544121
Jun 2022392710
Jul 202234278
Total609332401910